|
|
Office Locations:
|
300 Park Ave 16th Floor
New York, NY 10022
Phone: 212-895-3500
Fax: 212-895-3555
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Founded in 2002, Maxim Group is a leading full-service investment banking, securities and wealth management firm headquartered in New York. Since 2009, the Maxim Merchant Capital Division has closed more than $560,000,000 in traditional private and public financings. Within the biotech sector, Maxim looks for companies that address significant unmet needs and have a clear regulatory path. The firm's senior investment banking professionals have earned a strong reputation for providing financing and advisory solutions for emerging growth corporate clients generally from $1 Billion and below in total enterprise value. Over 140 transactions have been completed.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
